Douglas Braun, CSP, PharmD, RPh | Authors

Expert Commentary on the Product Profile of Umbralisib for Lymphoma

October 17, 2021

In an interview with ONCOLOGY®, Douglas Braun, CSP, PharmD, RPh, offers a comprehensive review of real-world treatment considerations of umbralisib as therapy for patients with previously treated follicular and marginal zone lymphoma.